USANA Health Sciences(US:USNA) ZACKS·2026-02-17 23:25分组1 - USANA Health Sciences reported quarterly earnings of $0.6 per share, exceeding the Zacks Consensus Estimate of $0.41 per share, but down from $0.64 per share a year ago, resulting in an earnings surprise of +46.34% [1] - The company achieved revenues of $226.2 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 0.11% and increasing from $213.61 million year-over-year [2] - USANA Health has outperformed the S&P 500, with shares rising about 6.5% since the beginning of the year, while the S&P 500 declined by 0.1% [3] 分组2 - The future performance of USANA Health's stock will largely depend on management's commentary during the earnings call and the company's earnings outlook [4][5] - The current consensus EPS estimate for the upcoming quarter is $0.40 on revenues of $237.63 million, and for the current fiscal year, it is $1.84 on revenues of $956.18 million [7] - The Medical - Drugs industry, to which USANA Health belongs, is currently ranked in the bottom 47% of over 250 Zacks industries, indicating potential challenges ahead [8]